Other European projects aimed at the development of pandemic influenza vaccines
PANFLUVAC (2007-2011)
Efficacious vaccine formulation system for prophylactic control of influenza pandemics.
[vaccine delivery systems for intranasal and parenteral vaccines]
INTRANASAL H5 VACCINE (2007-2010)
Immunogenicity and protective efficacy of intranasal H5N1 influenza vaccine.
[replication-deficient H5N1 intranasal vaccine]
FLUVAC (2007-2011)
Dose sparing and increased immunogenicity for vaccination against pandemic influenza with HT adjuvant
[formulation of inactivated cell-culture produced whole influenza H5N1 virus with a new adjuvant, CoVaccine HT]
NOVADUCK (2007-2010)
Novel AI DIVA recombinant vaccines for duck
[life vaccines based on new vector systems]
AIV VACC DIAGNOSIS (2006-2009)
Vaccine, diagnostic test development and immunology aspects of avian influenza
[orally applicable life and Newcastle disease or infectious laryngotracheitis vector vaccines]
SARS/FLU VACCINE (2005-2008)
Development of a combined influenza/SARS vaccine
[attenuated influenza used as vector for SARS antigen presentation]
UNIVERSAL VACCINE (2005-2007)
Novel antigen-adjuvant vehicle as an effective influenza vaccine
[intranasal influenza M2 peptide vaccine using a hepatitits B vector and the mucosal adjuvant CTAI-DD]
FLUAID(2006-2008)
Generation of information and tools to support the management of the avian influenza crisis in poultry.
[guidelines, pen-size diagnostic tests]
FLUVACC (2005-2010)
Live attenuated replication-defective influenza vaccine
[reverse genetics for LAIV strain production in cell-culture]
CHIMERIC VACCINES (2004-2008)
Development of influenza del NS1 virus as a vector for foreign antigens
[conservative epitopes presented on an apathogenic influenza vector]
NOVAFLU (2002-2006)
Novel vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.
[European surveillance system for influenza viruses in migratory birds, reverse genetics system development, mathematic influenza variation modeling]
FLUPAN (2001-2005)
Preparing for an influenza pandemic
[H7N1 vaccine developed by reverse genetics up into phase I clinical trials]
NASPANVAC (2008-2012)
Nasal pandemic Influenza Vaccine
[heat-stable intranasal vaccine with chitosan as adjuvant]